Clinical Research Unit

Bioskin Clinical Research Unit

European Unit: bioskin

bioskin is a leading full-service dermatology clinical research organization (CRO) in Europe, headquartered in Hamburg, Germany. bioskin manages and conducts clinical trials for drugs (Phase I - IV), cosmetics, nutraceuticals and medical devices. Services include protocol design, patient and investigator recruitment, monitoring, data management, statistics and medical writing.

Proof-of-concept Studies

bioskin offers innovative proof-of-concept test models for early evaluation of efficacy of topical drugs, using bioengineering methods to objectively evaluate endpoints. Test models include the Psoriasis Plaque Test, UV Erythema Test for anti-inflammatories, and the Vasoconstrictor Assay for glucocorticoids. Other test models tailored to your clinical development needs are also available.

Phase I – III Clinical Studies

bioskin manages and conducts phase I safety studies and phase II efficacy studies for a number of dermatological indications at its clinical units in Hamburg and Berlin Germany. A large database of healthy volunteers and patients profiled for skin condition and disease are maintained, assuring fast, reliable recruitment. bioskin also manages multicenter, multinational trials using a network of dermatologists and university hospitals throughout Europe, allowing recruitment of even difficult-to-find (naïve) and severely diseased patients.

Visit the bioskin.de Web site